Lisanti Capital Growth, LLC Care Dx, Inc. Transaction History

Lisanti Capital Growth, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$59.15 - $91.99 $9.66 Million - $15 Million	-163,255 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$63.02 - $95.11 $2.94 Million - $4.44 Million	46,725 Added 40.1%	163,255 $14.9 Million
Q1 2021 May 12, 2021	BUY	$57.62 - $95.6 $896,855 - $1.49 Million	15,565 Added 15.42%	116,530 $7.94 Million
Q4 2020 Feb 10, 2021	BUY	$41.43 - $77.09 $4.18 Million - $7.78 Million	100,965 New	100,965 $7.32 Million
Q3 2020 Nov 05, 2020	SELL	$30.88 - $37.94 $6.89 Million - $8.46 Million	-222,965 Closed	0 $0

Q2 2020 Aug 10, 2020	BUY	$18.95 - $35.43 $4.23 Million - $7.9 Million	222,965 New	222,965 $7.9 Million
Q3 2019 Nov 06, 2019	SELL	$20.03 - $40.08 $2.15 Million - $4.29 Million	-107,135 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$25.78 - $39.77 $1.42 Million - $2.19 Million	54,975 Added 105.4%	107,135 $3.86 Million
Q1 2019 May 13, 2019	SELL	$22.09 - $39.21 $366,804 - $651,082	-16,605 Reduced 24.15%	52,160 $1.64 Million
Q4 2018 Feb 08, 2019	BUY	$19.89 - $30.02 $1.37 Million - $2.06 Million	68,765 New	68,765 $1.73 Million

150

55.1M

85.8K

48.8K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $830M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.